According to a new study, patients with high risk macular degeneration showed improvement when they were treated with a high dose statin.
A new study reports L-DOPA may be able to delay or prevent macular degeneration associated with aging.
A new study reports the dietary supplement Omega 3 does not slow cognitive decline in older people, especially if they already have preexisting cognitive problems.
Treatment with Humanin G reduced protein levels of inflammation markers that become elevated in age-related macular degeneration.
A new study reveals a considerable link between three common eye diseases and an increased risk of developing Alzheimer's disease. Researchers believe their findings could help physicians better detect those at risk of developing dementia.
Following a Mediterranean diet with greater adherence was linked to the lowest risk of cognitive impairment. High fish and vegetable consumption appeared to have the greatest protective effect against cognitive decline.
Researchers link microscopic spheres of calcium phosphate to the development of AMD.
Exposing retinal pigment epithelium cells in mouse models to amyloid-beta resulted in retinal pathologies similar to those seen in human age-related macular degeneration.
Age-related macular degeneration and lupus share a common contributor to inflammation. The findings could help researchers develop new treatments for those conditions, and other conditions associated with inflammation.
A new study could help explain why our peripheral vision is so poor.
Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.
The AREDS2 dietary supplement that substitutes antioxidants lutein and zeaxanthin for beta-carotene reduces the risk of age-related macular degeneration progression, a new study reveals.
